Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T12:50:25.459Z.
Calculation as of: 2026-10-06T12:50:25.459Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$2.64B
Price/FCF Ratio
N/A
TTM Avg
44.80
3Y Avg
44.80
5Y Avg
44.80
Market Cap
$2.69B
Price/FCF Ratio
N/A
TTM Avg
146.96
3Y Avg
80.20
5Y Avg
82.43
Market Cap
$2.69B
Price/FCF Ratio
17.01
TTM Avg
18.59
3Y Avg
43.84
5Y Avg
62.13
Market Cap
$2.51B
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.43B
Price/FCF Ratio
32.68
TTM Avg
38.73
3Y Avg
40.68
5Y Avg
38.72
Market Cap
$2.87B
Price/FCF Ratio
36.29
TTM Avg
52.84
3Y Avg
87.29
5Y Avg
87.29
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | N/A | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | N/A | 44.80 | 44.80 | 44.80 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | N/A | 146.96 | 80.20 | 82.43 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 17.01 | 18.59 | 43.84 | 62.13 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 32.68 | 38.73 | 40.68 | 38.72 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 55.87 | 72.35 | 93.08 | 93.08 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 36.29 | 52.84 | 87.29 | 87.29 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 20.12 | 65.29 | 92.84 | 92.84 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
